Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA426645
Max Phase: Preclinical
Molecular Formula: C20H14FNO4
Molecular Weight: 351.33
Molecule Type: Small molecule
Associated Items:
ID: ALA426645
Max Phase: Preclinical
Molecular Formula: C20H14FNO4
Molecular Weight: 351.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1cccc(F)c1C(=O)O)c1cccc(Oc2ccccc2)c1
Standard InChI: InChI=1S/C20H14FNO4/c21-16-10-5-11-17(18(16)20(24)25)22-19(23)13-6-4-9-15(12-13)26-14-7-2-1-3-8-14/h1-12H,(H,22,23)(H,24,25)
Standard InChI Key: MUCVEZAGZUMXAG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 351.33 | Molecular Weight (Monoisotopic): 351.0907 | AlogP: 4.57 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.63 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.78 | CX Basic pKa: | CX LogP: 5.02 | CX LogD: 1.52 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -1.24 |
1. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S.. (2005) Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents., 48 (5): [PMID:15743201] [10.1021/jm049141s] |
Source(1):